glp 1 serotonin Psychotropic effects of GLP-1R agonists Sympathetic nerve-enteroendocrine L cell communication

Type 2 diabetes mellitus (DM2) affects a 13.8% of the Spanish population1 and its prevalence is expected to increase in the future.2 The presence of DM2 increases significantly the risk of cardiovascular events, chronic kidney disease (CKD), and premature death3,4 and as its prevalence increases it is expected to rise the incidence of microvascular and macrovascular complications.5 Until the last decade, the control of blood glucose, blood pressure, dyslipidemia, and the use of inhibitors of the renin-angiotensin system (iSRA) have been the only strategies available to reduce cardiovascular and renal risk in this population

J New Drugs

Heres how you can maximize their benefits without compromising results

Fat loss Finland Clinical studies have shown significant results when using Melanotan 2 for weight loss

SURMOUNT-4 examined what happens when patients continue treatment versus stop

For these tough cases, you have to bring out the organic solvents